"Successfully treating pain requires skill, patience, empathy and staying current within our field. We are committed to a personalized approach to treating an array of conditions and comprehensive treatment plans to improve your quality of life."

During the past decade, National Pain Research Institute, LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Pain Research Institute, LLC" are "Low Back Pain" (4 trials), "Neuropathic Pain" (1 trials), "Osteoarthritis" (1 trials) and "Osteoarthritis of the Knee" (1 trials). Many other conditions were trialed in "National Pain Research Institute, LLC" in a lesser frequency.

Most popular intervention types in "National Pain Research Institute, LLC" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Buprenorphine" (2 trials), "1.2% Sodium Hyaluronate" (1 trials), "Buffered Saline" (1 trials) and "EN3409" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Pain Research Institute, LLC" are 5 trials for "All" genders.

Currently, there are NaN active trials in "National Pain Research Institute, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in National Pain Research Institute, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Pain Research Institute, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".